What is Amivantamab: Uses, Dosage, Side Effects and More

Amivantamab is a targeted cancer medicine that helps treat certain types of lung cancer. It's a specialized therapy designed to block specific proteins that help cancer cells grow and spread throughout your body.

This medication belongs to a newer class of cancer treatments called bispecific antibodies. Think of it as a precision tool that targets two different pathways cancer cells use to survive, rather than affecting all rapidly dividing cells like traditional chemotherapy does.

What is Amivantamab Used For?

Amivantamab treats adults with non-small cell lung cancer (NSCLC) that has specific genetic changes. Your doctor will order special tests to determine if your cancer has the right characteristics for this treatment to work effectively.

The medication specifically targets lung cancers with EGFR exon 20 insertion mutations. These are particular genetic changes that make cancer cells grow differently than other types of lung cancer. Your oncologist will explain whether your specific cancer type matches what this medicine can treat.

This treatment is typically used when your cancer has spread to other parts of your body or when previous treatments haven't worked as well as hoped. Your medical team will carefully evaluate your overall health and cancer characteristics before recommending this option.

How Does Amivantamab Work?

Amivantamab works by blocking two important proteins that cancer cells need to grow and survive. It targets both EGFR and MET receptors, which are like switches that tell cancer cells to multiply and spread.

This medication is considered a moderately strong cancer treatment. It's more targeted than traditional chemotherapy, which means it focuses specifically on cancer cells rather than affecting all fast-growing cells in your body. This precision approach can lead to fewer side effects compared to conventional treatments.

The medicine also activates your immune system to help fight the cancer. It works like a bridge, connecting your body's natural defense cells to the cancer cells, making it easier for your immune system to recognize and attack the tumor.

How Should I Take Amivantamab?

Amivantamab is given as an intravenous (IV) infusion directly into your bloodstream at a cancer treatment center or hospital. You cannot take this medication at home, as it requires careful monitoring by trained healthcare professionals.

Before each infusion, your medical team will give you pre-medications to help prevent allergic reactions. These usually include antihistamines, steroids, and fever reducers. You'll receive these about 30 to 60 minutes before your amivantamab treatment begins.

The infusion process typically takes several hours during your first treatment, as your healthcare team will start slowly and gradually increase the rate if you tolerate it well. Subsequent treatments may be shorter once your body adjusts to the medication.

You don't need to fast before treatment, but eating a light meal beforehand can help you feel more comfortable during the long infusion process. Stay well-hydrated by drinking plenty of water in the days leading up to your treatment.

How Long Should I Take Amivantamab For?

The duration of amivantamab treatment varies significantly from person to person, depending on how well your cancer responds and how you tolerate the medication. Some people continue treatment for many months, while others may need to stop earlier due to side effects or disease progression.

Your oncologist will monitor your progress through regular scans and blood tests to determine if the treatment is working effectively. These check-ups help your medical team decide whether to continue, adjust, or change your treatment plan.

Treatment typically continues as long as your cancer is stable or shrinking and you're not experiencing severe side effects. If the cancer begins growing again or if side effects become too difficult to manage, your doctor will discuss other treatment options with you.

What Are the Side Effects of Amivantamab?

Like most cancer treatments, amivantamab can cause side effects, though not everyone experiences them the same way. Many people tolerate this medication reasonably well, especially compared to traditional chemotherapy.

The most common side effects you might experience include skin reactions, nail changes, and digestive issues. Understanding what to expect can help you prepare and know when to contact your healthcare team for support.

Here are the side effects you're most likely to encounter:

• Skin rash or acne-like breakouts, especially on your face and chest
• Nail changes, including pain, swelling, or infections around your nails
• Diarrhea or loose stools
• Nausea or loss of appetite
• Fatigue or feeling more tired than usual
• Muscle or joint pain
• Swelling in your hands, feet, or around your eyes

These common side effects are usually manageable with supportive care and medications your doctor can prescribe. Most people find that side effects become more tolerable as their body adjusts to the treatment.

While less common, some people may experience more serious side effects that require immediate medical attention. These rare but important complications can include:

• Severe infusion reactions with difficulty breathing, chest pain, or severe rash
• Serious lung problems (pneumonitis) causing persistent cough or shortness of breath
• Heart problems, including irregular heartbeat or chest pain
• Severe skin reactions that cover large areas of your body
• Eye problems, including vision changes or severe eye pain
• Blood clots in your lungs or legs

If you experience any of these serious symptoms, contact your healthcare team immediately or go to the emergency room. Your medical team will provide you with detailed instructions about which symptoms require urgent attention.

Who Should Not Take Amivantamab?

Amivantamab isn't suitable for everyone, and your oncologist will carefully evaluate whether it's the right choice for your specific situation. Several factors influence whether this treatment is appropriate for you.

You should not receive amivantamab if you've had a severe allergic reaction to this medication or any of its ingredients in the past. Your doctor will discuss your allergy history thoroughly before starting treatment.

People with certain heart conditions, severe lung disease, or active infections may need alternative treatments or additional monitoring. Your medical team will review your complete medical history to ensure this treatment is safe for you.

If you're pregnant or planning to become pregnant, amivantamab is not recommended as it can harm your developing baby. Women of childbearing age should use effective birth control during treatment and for several months afterward.

Amivantamab Brand Names

Amivantamab is available under the brand name Rybrevant. This is the only brand name currently available for this medication in the United States and many other countries.

Your insurance company and pharmacy will recognize the medication by either its generic name (amivantamab) or brand name (Rybrevant). Both names refer to the exact same medication, so don't worry if you see either one on your medical records or treatment paperwork.

Amivantamab Alternatives

If amivantamab isn't suitable for you or stops working effectively, several other treatment options may be available. The best alternative depends on your specific type of lung cancer and previous treatments you've received.

Other targeted therapies for EGFR-positive lung cancer include medications like osimertinib, erlotinib, or afatinib. However, these work differently than amivantamab and may not be effective for the same genetic mutations.

Traditional chemotherapy combinations remain important treatment options, especially when targeted therapies are no longer effective. Immunotherapy drugs like pembrolizumab or nivolumab might also be considered, depending on your cancer's characteristics.

Your oncologist will discuss all available options with you, taking into account your cancer's specific features, your overall health, and your treatment preferences.

Is Amivantamab Better Than Other EGFR Inhibitors?

Amivantamab offers unique advantages compared to other EGFR inhibitors, particularly for specific types of lung cancer mutations. It's designed to work against EGFR exon 20 insertion mutations, which don't respond well to older EGFR inhibitors like erlotinib or gefitinib.

The main advantage of amivantamab is its dual targeting approach. While traditional EGFR inhibitors focus on one protein pathway, amivantamab blocks both EGFR and MET receptors, potentially making it more effective against resistant cancer cells.

However, "better" depends on your specific situation. Some people may experience fewer side effects with oral EGFR inhibitors, while others respond better to amivantamab's targeted approach. Your oncologist will help determine which treatment offers the best balance of effectiveness and tolerability for your individual case.